$300M Baseten and $130M Solace rounds put IVP at the center of recent coverage of large AI-infrastructure, health-care and security financings.
IVP appears in the coverage as a venture investor, chiefly as lead or co-lead in growth-stage funding rounds. Its stories span AI software and infrastructure, enterprise security, health-care workflow tools, developer platforms and consumer or gaming technology, with earlier appearances alongside investors including Bain Capital, a16z, Fidelity and GV.
Coverage reached its recent high in 2026 Q1 after a more sustained return beginning in 2024. The immediate drivers were IVP-led financings for identity-security company Venice and health-care navigation startup Solace, plus reports that IVP and CapitalG led Baseten's $300M round, in which Nvidia also invested. The latter remains reported rather than confirmed in the supplied relationships.
The preceding cycle sharpened IVP's association with AI: Perplexity's $74M round in early 2024 was followed by reporting on a proposed $500M IVP-led round, while Cradle, LangChain and Tennr brought AI protein design, application development and health-care automation into the portfolio narrative. Appcharge's $58M Series B shows the coverage has not become exclusively AI-focused.
The central tension is IVP's push toward companies exposed to the AI buildout while investing across sectors where AI is applied. Baseten places it alongside CapitalG and Nvidia in inference infrastructure, whereas Perplexity and LangChain point to the application layer; Tennr, Solace and Venice extend the same investment logic into regulated health-care and identity-security settings. The coverage consequently tracks both high valuations and the question of which layer of the stack produces durable businesses.
If this trajectory continues, IVP's coverage will serve as a useful signal of where late-stage capital is concentrating across AI infrastructure and enterprise adoption rather than in a single software category. The mix of Baseten, LangChain, Perplexity, Venice and health-care companies suggests a portfolio thesis that can benefit from broader AI deployment, though reported financing terms and valuations alone do not establish which of these markets will sustain their current momentum.
IVP has appeared in 67 articles since 2012-11. Coverage peaked in 2026Q1 with 5 articles. Frequently mentioned alongside TechCrunch, Ingrid Lunden, London, Baseten.